
If Pfizer’s data pans out, when will little kids get the COVID-19 vaccine?
WASHINGTON — A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune
.grecaptcha-badge { visibility: hidden; }
Skip to content